AI retinal disease platform
Retinal diseases (AMD, diabetic retinopathy, etc.)
Pre‑clinical/early clinicalActive
Key Facts
Indication
Retinal diseases (AMD, diabetic retinopathy, etc.)
Phase
Pre‑clinical/early clinical
Status
Active
Company
About BioLight
Israel's sole publicly listed ophthalmology‑focused investment platform, BioLight builds a diversified portfolio of innovative eye‑care technologies.
View full company profile